In part two of SBC's Bookies Corner, we’ll be analysing the culture around racing and the hype surrounding this week's Cheltenham Festival.

GB takes a closer look at how operators performed in LatAm across FY2025, with Brazil again a key focus for companies.

With INTA 2026 just two months away, London-based IP practitioners offer tips on making the most out of the city ...

Mounting evidence suggests that antiganglioside antibodies play a crucial role in the pathogenesis of Guillain–Barré syndrome (GBS) and its variants. Among them, anti-GT1a ganglioside immunoglobulin G ...

Kim Kardashian is serving style with her latest SKIMS campaign. The reality TV star recently posed for the cameras to show ...

Ocular Therapeutix (OCUL) lost ~22% in the premarket on Tuesday after the company released data from a late-stage trial evaluating Axpaxli, its experimental therapy for wet age-related macular ...

Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched position in wet age-related macular degeneration (AMD) with investigational ...

⚠️ Middle East tensions = Portfolio impacts. Know your exposure NOW Ask WarrenAI Ocular Therapeutix stock news: Why positive data led to a 25% drop By Author Louis Juricic Stock Markets ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

BEDFORD, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Ocular Therapeutix granted ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...